ORBIMED ADVISORS LLC — Form 4 insider transactions

ORBIMED ADVISORS LLC — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-11-10 Buy Electra Therapeutics, Inc. 2,000 $8.45 $16,900 SEC filing
2026-11-10 Buy Electra Therapeutics, Inc. 20,700 $8.45 $174,915 SEC filing
2026-11-09 Buy Electra Therapeutics, Inc. 16,000 $8.24 $131,840 SEC filing
2026-11-09 Buy Electra Therapeutics, Inc. 4,000 $8.24 $32,960 SEC filing
2026-11-06 Buy Electra Therapeutics, Inc. 39,600 $7.85 $310,860 SEC filing
2026-11-06 Buy Electra Therapeutics, Inc. 9,816 $7.85 $77,056 SEC filing
2026-11-05 Buy Electra Therapeutics, Inc. 125,200 $7.31 $915,212 SEC filing
2026-11-05 Buy Electra Therapeutics, Inc. 30,891 $7.31 $225,813 SEC filing
2026-11-04 Buy Electra Therapeutics, Inc. 20,000 $7.07 $141,400 SEC filing
2026-11-04 Buy Electra Therapeutics, Inc. 5,000 $7.07 $35,350 SEC filing
2026-11-04 Buy Electra Therapeutics, Inc. 37,100 $7.78 $288,638 SEC filing
2026-11-04 Buy Electra Therapeutics, Inc. 9,267 $7.78 $72,097 SEC filing
2026-11-03 Buy Electra Therapeutics, Inc. 98,600 $7.88 $776,968 SEC filing
2026-11-03 Buy Electra Therapeutics, Inc. 24,400 $7.88 $192,272 SEC filing
2026-11-03 Buy Electra Therapeutics, Inc. 97,800 $7.84 $766,752 SEC filing
2026-11-03 Buy Electra Therapeutics, Inc. 24,313 $7.84 $190,614 SEC filing
2026-11-02 Buy Aspen Neuroscience, Inc. 1,000,000 $15.00 $15,000,000 SEC filing
2026-11-02 Conversion Aspen Neuroscience, Inc. 507,119 — — SEC filing
2026-11-02 Conversion Aspen Neuroscience, Inc. 625,743 — — SEC filing
2026-11-02 Conversion Aspen Neuroscience, Inc. 616,984 — — SEC filing
2026-11-02 Conversion Aspen Neuroscience, Inc. 642,745 — — SEC filing
2026-11-02 Conversion Aspen Neuroscience, Inc. 196,541 — — SEC filing
2026-09-28 Buy ADARx Pharmaceuticals, Inc. 588,235 $17.00 $9,999,995 SEC filing
2026-09-28 Buy ADARx Pharmaceuticals, Inc. 61,516 $17.00 $1,045,772 SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 256,448 — — SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 513,067 — — SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 1,333,975 — — SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 7,127,019 — — SEC filing
2026-09-28 Buy ADARx Pharmaceuticals, Inc. 300,249 $17.00 $5,104,233 SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 564,187 — — SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 769,601 — — SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 2,000,962 — — SEC filing
2026-09-28 Conversion ADARx Pharmaceuticals, Inc. 10,690,530 — — SEC filing
2026-09-21 Buy Electra Therapeutics, Inc. 1,000,000 $15.00 $15,000,000 SEC filing
2026-09-21 Conversion Electra Therapeutics, Inc. 758,279 — — SEC filing
2026-09-21 Buy Electra Therapeutics, Inc. 333,333 $15.00 $4,999,995 SEC filing
2026-09-21 Conversion Electra Therapeutics, Inc. 1,703,314 — — SEC filing
2026-09-21 Conversion Electra Therapeutics, Inc. 1,087,934 — — SEC filing
2026-09-21 Conversion Electra Therapeutics, Inc. 2,002,310 — — SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 625,000 $16.00 $10,000,000 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,049,283 — — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,039,996 — — SEC filing
2026-08-07 Buy Braveheart Bio, Inc. 273,333 $18.00 $4,919,994 SEC filing
2026-08-07 Buy Braveheart Bio, Inc. 1,666,667 $18.00 $30,000,006 SEC filing
2026-08-07 Conversion Braveheart Bio, Inc. 9,132,420 — — SEC filing
2026-07-27 Buy Scribe Therapeutics, Inc. 1,000,000 $15.00 $15,000,000 SEC filing
2026-07-27 Conversion Scribe Therapeutics, Inc. 348,825 — — SEC filing
2026-07-07 Sell Sionna Therapeutics, Inc. 85,918 $44.86 $3,854,281 SEC filing
2026-06-30 Sell Sionna Therapeutics, Inc. 115,844 $45.50 $5,270,902 SEC filing
2026-06-22 Sell Enliven Therapeutics, Inc. 46,776 $45.00 $2,104,920 SEC filing
2026-06-22 Sell Enliven Therapeutics, Inc. 787,024 $45.38 $35,715,149 SEC filing
2026-06-22 Sell Enliven Therapeutics, Inc. 1,477 $45.00 $66,465 SEC filing
2026-06-22 Sell Enliven Therapeutics, Inc. 24,846 $45.38 $1,127,511 SEC filing
2026-06-15 Sell Enliven Therapeutics, Inc. 272,322 $45.02 $12,259,936 SEC filing
2026-06-15 Sell Enliven Therapeutics, Inc. 9,086 $45.02 $409,052 SEC filing
2026-05-28 Buy Q32 Bio Inc. 625,000 $8.00 $5,000,000 SEC filing
2026-05-28 Buy Q32 Bio Inc. 1,250,000 $8.00 $10,000,000 SEC filing
2026-05-27 Sell Sionna Therapeutics, Inc. 101 $44.49 $4,493 SEC filing
2026-05-11 Sell Sionna Therapeutics, Inc. 184,639 $46.22 $8,534,015 SEC filing
2026-05-08 Sell Sionna Therapeutics, Inc. 59,767 $44.58 $2,664,413 SEC filing
2026-05-07 Sell Sionna Therapeutics, Inc. 48,546 $44.61 $2,165,637 SEC filing
2026-04-16 Buy Traws Pharma, Inc. 597,729 $1.67 $998,207 SEC filing
2026-04-21 Buy Prelude Therapeutics Inc 1,126,126 $4.44 $4,999,999 SEC filing
2026-04-21 Buy Prelude Therapeutics Inc 1,689,189 $4.44 $7,499,999 SEC filing
2026-04-18 Sell Sionna Therapeutics, Inc. 2,948 $44.52 $131,245 SEC filing
2026-04-17 Sell Sionna Therapeutics, Inc. 52,397 $44.68 $2,341,098 SEC filing
2026-04-16 Sell Sionna Therapeutics, Inc. 226,906 $45.34 $10,287,918 SEC filing
2026-04-15 Sell Sionna Therapeutics, Inc. 235,863 $44.64 $10,528,924 SEC filing
2026-04-14 Sell Sionna Therapeutics, Inc. 47,814 $44.51 $2,128,201 SEC filing
2026-04-08 Sell Adicet Bio, Inc. 40,416 $6.52 $263,512 SEC filing
2026-04-08 Sell Adicet Bio, Inc. 32,523 $6.29 $204,570 SEC filing
2026-04-07 Sell Adicet Bio, Inc. 2,400 $6.38 $15,312 SEC filing
2026-04-07 Sell Adicet Bio, Inc. 29,319 $6.53 $191,453 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →